A Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP Compared to RCHOP in Subjects with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

  • Wong, Shu (Primary Chief Investigator (PCI))
  • Tatarczuch, Maciej (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date20/04/23 → 20/04/25

Keywords

  • clinical trial
  • B-Cell Lymphoma
  • Large diffuse lymphoma
  • RCHOP